Bridging the gaps between Radiology, Urology & Oncology, Eigen improves healthcare and quality of life through innovative breakthroughs in image-guided disease diagnosis and treatment. Our ingenuity and foresight, coupled with our ongoing involvement with the scientific and medical communities, positions us at the vanguard of emerging technology used for detecting, localizing and managing prostate cancer. Eigen holds numerous patents in its growing intellectual property portfolio.
Eigen adheres to the highest standard in medical device regulatory compliance. We place great importance on effective risk management, as well as the best practices specific to safe medical device design, manufacture and installation. Demonstrating overall industry excellence, ISO 13485 certification aligns Eigen with international regulatory requirements and permits us to pursue sales and distribution in Canada, EU countries, other European countries, Latin America, Iran, Turkey, China, HK, Philippines, Korea, Turkey, India, Mexico in addition to our leading role throughout the USA.
Eigen adheres to the highest standard in medical device regulatory compliance. We place great importance on effective risk management, as well as the best practices specific to safe medical device design, manufacture and installation. Demonstrating overall industry excellence, ISO 13485 certification aligns Eigen with international regulatory requirements and permits us to pursue sales and distribution in Canada, EU countries, other European countries, Latin America, Iran, Turkey, China, HK, Philippines, Korea, Turkey, India, Mexico in addition to our leading role throughout the USA.
Founded date: 1975
Investors 2
| Date | Name | Website |
| - | Qiming Ven... | qimingvent... |
| - | Qiming Ven... | qimingvc.c... |
Mentions in press and media 6
| Date | Title | Description |
| 13.03.2020 | London-based Eigen Technology closes Series B round at $42 million | With an additional $5 million investment from ING Ventures, London-based Eigen Technologies has sealed its Series B round at $42 million, after an initial close last November. The round was led by Lakestar and Dawn Capital, with Temasek and... |
| 14.11.2019 | Eigen nabs $37M to help banks and others parse huge documents using natural language and ‘small data’ | One of the bigger trends in enterprise software has been the emergence of startups building tools to make the benefits of artificial intelligence technology more accessible to non-tech companies. Today, one that has built a platform to appl... |
| 14.03.2019 | Fredericton-based Eigen Innovations receives $800,000 government funding | Eigen Innovations, an AI-based IoT software company, has received $800,000 in funding from the federal government’s Atlantic Canada Opportunities Agency (ACOA). The funding comes in the form of a conditionally repayable contribution of $708... |
| 11.06.2018 | Eigen Technologies Raises $17.5M Series A | Eigen Technologies, the research-led artificial intelligence company for finance, law, and professional services, has completed a £13m ($17.5m) Series A funding round co-led by Goldman Sachs Principal Strategic Investments (PSI) and Temasek... |
| 22.04.2016 | Eigen Innovations closes $1.4M round, changes management | FREDERICTON, N.B. (22/04/2016)—Eigen innovations Inc., today announced changes to its financing and management team. Eigen’s Intellexon® platform provides vision systems, sensors, and software that automatically detect, learn, and correct d... |
| 12.05.2015 | NBIF Invests $250K In Eigen Innovations |